- Q1 2024 BioNTech SE Earnings Call TranscriptMay 06, 2024$93.35 (+0.68%)Earnings
- Q4 2023 BioNTech SE Earnings Call TranscriptMar 20, 2024$90 (-4.38%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- BioNTech SE Inaugurates its First African Site in Kigali TranscriptDec 18, 2023
- BioNTech SE Capital Markets Day TranscriptNov 07, 2023
- Q3 2023 BioNTech SE Earnings Call TranscriptNov 06, 2023$99.71 (+4.10%)Earnings
- Q2 2023 BioNTech SE Earnings Call TranscriptAug 07, 2023$98.5 (-7.49%)Earnings
- Q1 2023 BioNTech SE Earnings Call TranscriptMay 08, 2023$108.05 (-0.35%)Earnings
- Q4 2022 BioNTech SE Earnings Call TranscriptMar 27, 2023$123.6 (-3.59%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 BioNTech SE Earnings Call TranscriptNov 07, 2022$160.72 (+4.15%)Earnings
- Q2 2022 BioNTech SE Earnings Call TranscriptAug 08, 2022$169.3 (-7.54%)Earnings
- BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call TranscriptJun 29, 2022
- Q1 2022 BioNTech SE Earnings Call TranscriptMay 09, 2022$140.32 (+3.05%)Earnings
- Q4 2021 BioNTech SE Earnings Call TranscriptMar 30, 2022$174.78 (+1.39%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call TranscriptDec 08, 2021
- Q3 2021 BioNTech SE Earnings Call TranscriptNov 09, 2021$226.37 (-6.69%)Earnings
- Q2 2021 BioNTech SE Earnings Call TranscriptAug 09, 2021$447.23 (+14.97%)Earnings
- BioNTech SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- BioNTech SE at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- BioNTech SE at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q1 2021 BioNTech SE Earnings Call TranscriptMay 10, 2021$202.35 (+10.15%)Earnings
- BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 31, 2021
- Q4 2020 BioNTech SE Earnings Call TranscriptMar 30, 2021$104.44 (+8.89%)Earnings
- BioNTech SE at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- BioNTech SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 BioNTech SE Earnings Call TranscriptNov 10, 2020$112.76 (+7.60%)Earnings
- Q2 2020 BioNTech SE Earnings Call TranscriptAug 11, 2020$68.45 (-7.44%)Earnings
- BioNTech SE To Present Early Positive Data From Ongoing Phase 1/2 Study of mRNA-Based Vaccine Candidate Against SARS-CoV-2 Call TranscriptJul 01, 2020
- BioNTech SE at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioNTech SE Earnings Call TranscriptMay 12, 2020$49.33 (-1.30%)Earnings
- BioNTech SE - Special Call TranscriptApr 23, 2020
- Full Year 2019 BioNTech SE Earnings Call TranscriptMar 31, 2020$58.4 (-5.81%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 BioNTech SE Earnings Call TranscriptNov 14, 2019$19 (+2.43%)Earnings
BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call Transcript
Welcome to our digital press conference to provide an update on the Omicron variant. We will start with a presentation by our CEO and Co-Founder, Ugur Sahin, followed by a Q&A session. Ugur, let me hand over to you.
Thank you, Natasha. Hi, everyone. We are here today to present our first preliminary data from a laboratory test evaluating the authorization of the new Omicron spike variant in laboratory assays.
So let me start just with the short disclosures and with some background information. The Omicron -- new Omicron variant, also known as B11529, has multiple mutation at sites which are known to be relevant for binding of the neutralizing antibodies in the spike protein. In total, total, there are 34 to 35 mutations. These mutations are at sites of the receptor binding domain, which directly binds to the ACE2 receptor on target cells as well as in the [internal] domain, which is known to harbor also neutralizing antibody sites.
Many of these mutations, which
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)